Fig. 2

The distinct genetic profile in PIKK-mutated patients. A The oncoprint plot of the genetic profile for NSCLC patients with either ATM or ATR pathogenic mutations from the study cohort. The patient (P145) who harbored both ATM and ATR pathogenic mutations was not included. B The mutated genes that were significantly enriched in PIKK-mutated patients from the study cohort. The analyses were done using Fisher’s exact test, and all multiple comparisons were corrected by the Benjamini & Hochberg approach